» Articles » PMID: 976935

Purification and Characterization of a Protein from Porcine Gut with Glucagon-like Immunoreactivity

Overview
Journal Horm Metab Res
Specialty Endocrinology
Date 1976 Sep 1
PMID 976935
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

A protein with glucagon-like immunoreactivity has been isolated from porcine intestine in a highly purified form. The isoelectric point is 6.8-6.9, and the molecular weight is 11,625, as calculated from its amino acid composition: this estimate has been confirmed by S.D.S. gel electrophoresis. The partial sequence so far elucidated is from the N-terminal: Arg-Ser-Leu-Gin-Asn-Thr-Glx-Glx-Lys-Ala-Arg-Ser-Phe-, and from the C-terminal: -Ile-Ala, both differing from those of porcine pancreatic glucagon. On a molar basis the protein has the same immunoreactivity as porcine glucagon when assayed with some anti-glucagon sera, while the activity is less than 0.2% using other anti-glucagon sera.

Citing Articles

Annual Prize Lecture 2024: Endogenous physiological mechanisms as basis for the treatment of obesity and type 2 diabetes.

Holst J J Physiol. 2024; 602(24):6613-6629.

PMID: 39520693 PMC: 11649525. DOI: 10.1113/JP287461.


Striking the Balance: GLP-1/Glucagon Co-Agonism as a Treatment Strategy for Obesity.

Hope D, Vincent M, Tan T Front Endocrinol (Lausanne). 2021; 12:735019.

PMID: 34566894 PMC: 8457634. DOI: 10.3389/fendo.2021.735019.


The Enigmatic N-Terminal Domain of Proglucagon; A Historical Perspective.

Conlon J Front Endocrinol (Lausanne). 2021; 12:683089.

PMID: 34177808 PMC: 8226317. DOI: 10.3389/fendo.2021.683089.


Proglucagon-Derived Peptides as Therapeutics.

Lafferty R, Oharte F, Irwin N, Gault V, Flatt P Front Endocrinol (Lausanne). 2021; 12:689678.

PMID: 34093449 PMC: 8171296. DOI: 10.3389/fendo.2021.689678.


Glucagon-like peptide 1 (GLP-1).

Muller T, Finan B, Bloom S, DAlessio D, Drucker D, Flatt P Mol Metab. 2019; 30:72-130.

PMID: 31767182 PMC: 6812410. DOI: 10.1016/j.molmet.2019.09.010.